Detection of malignant liver tumors and intrahepatic bile ducts in the Republic of Sakha (Yakutia)
https://doi.org/10.25789/YMJ.2025.90.19
Abstract
The article presents a cross-sectional retrospective study of cases of malignant neoplasms (MN) of the liver and intrahepatic bile ducts (C22) in the Republic of Sakha (Yakutia) (RS (Y) for 2010–2019 based on statistical registration forms No. 7 and 35. During the study period, significantly increased levels of morbidity and mortality from malignant neoplasms of the liver and intrahepatic bile ducts were recorded. At the same time, the proportion of detection of the studied pathology at early stages remains low, despite the strengthening of diagnostic measures within the framework of preventive examinations and screening programs. In the dynamics for 2015–2019 in the RS (Y), the proportion of patients with MN of the liver and intrahepatic bile ducts who were under observation for 5 years decreased, while the contingent of patients with this pathology increased. The obtained data substantiate the need to improve organizational approaches to early diagnosis and treatment, optimize patient routing, and study pre-cancerous factors of liver cancer in residents of the Republic of Sakha (Yakutia).
About the Authors
P. V. Nikiforov
ГБУ РС(Я) «Якутский республиканский онкологический диспансер»; СВФУ им. М.К. Аммосова, Медицинский институт
Russian Federation
Russian Federation
L. N. Afanasyeva
СВФУ им. М.К. Аммосова, Медицинский институт
Russian Federation
Russian Federation
T. M. Klimova
СВФУ им. М.К. Аммосова
Russian Federation
Russian Federation
T. I. Nikolaeva
ГБУ РС(Я) «Якутский республиканский онкологический диспансер»; СВФУ им. М.К. Аммосова
Russian Federation
Russian Federation
F. G. Ivanova
ГБУ РС(Я) «Якутский республиканский онкологический диспансер»
Russian Federation
Russian Federation
References
1. Sentinel lymph node biopsy in breast cancer using the indocyanine green fluorescent imaging method / A.D. Zikiryakhodjaev, E.K. Saribekyan, D.V. Bagdasarova [et al.] // Biomedical Photonics. 2019. V. 8, No. 4. Р. 4–10. doi: 10.24931/2413–9432–2019–8–4–4–10.
2. Biopsy of signaling lymph nodes in early breast cancer: the experience of the N.N. Petrov Research Institute of Oncology / P. Krivorotko, K. Zernov, R. Paltuev [et al.] // Questions of oncology. 2017. 63(2). Р. 267-273. https://doi.org/10.37469/0507-3758 .
3. The state of oncological care for the Russian population in 2022 / Edited by A.D. Kaprin, V.V. Starinsky, A.O. Shakhzadova. Moscow: P.A. Herzen Moscow Institute of Medical Sciences − branch of the Federal State Budgetary Institution "NMITS of Radiology" of the Ministry of Health of the Russian Federation, 2023. fig. 254 p.
4. Akrida I, Michalopoulos NV, Lagadinou M, Papadoliopoulou M, Maroulis I, Mulita F. An Updated Review on the Emerging Role of Indocyanine Green (ICG) as a Sentinel Lymph Node Tracer in Breast Cancer. Cancers (Basel). 2023 Dec 8;15(24):5755. doi: 10.3390/cancers15245755. PMID: 38136301; PMCID: PMC10742210.
5. Alsunitan RI, Al-Saif A, Alyousef BA, Alghamdi SM, Bugshan SA. Axillary Recurrence in Breast Cancer Patients After Negative Sentinel Lymph Node Biopsy: Retrospective Cohort Study From Riyadh, Saudi Arabia. Cureus. 2021 Dec 3;13(12):e20132. doi: 10.7759/cureus.20132. PMID: 34900499; PMCID: PMC8649977.
6. Goonawardena J, Yong C, Law M. Use of indocyanine green fluorescence compared to radioisotope for sentinel lymph node biopsy in early-stage breast cancer: systematic review and meta-analysis. Am J Surg. 2020 Sep;220(3):665676. doi: 10.1016/j.amjsurg.2020.02.001. Epub 2020 Feb 7. PMID: 32115177.
7. Inoue T, Nishi T, Nakano Y, Nishimae A, Sawai Y, Yamasaki M, Inaji H. Axillary lymph node recurrence after sentinel lymph node biopsy performed using a combination of indocyanine green fluorescence and the blue dye method in early breast cancer. Breast Cancer. 2016 Mar;23(2):295-300. doi: 10.1007/s12282-014-0573-8. Epub 2014 Oct 28. PMID: 25348937.
8. Jung SY, Han JH, Park SJ, Lee EG, Kwak J, Kim SH, Lee MH, Lee ES, Kang HS, Lee KS, Park IH, Sim SH, Jeong HJ, Kwon Y, Lee DE, Kim SK, Lee S. The Sentinel Lymph Node Biopsy Using Indocyanine Green Fluorescence Plus Radioisotope Method Compared With the Radioisotope-Only Method for Breast Cancer Patients After Neoadjuvant Chemotherapy: A Prospective, Randomized, Open-Label, Single-Center Phase 2 Trial. Ann Surg Oncol. 2019 Aug;26(8):2409-2416. doi: 10.1245/s10434-01907400-0. Epub 2019 May 7. PMID: 31065958
9. Jung SY, Kim SK, Kim SW, Kwon Y, Lee ES, Kang HS, Ko KL, Shin KH, Lee KS, Park IH, Ro J, Jeong HJ, Joo J, Kang SH, Lee S. Comparison of sentinel lymph node biopsy guided by the multimodal method of indocyanine green fluorescence, radioisotope, and blue dye versus the radioisotope method in breast cancer: a randomized controlled trial. Ann Surg Oncol. 2014 Apr;21(4):1254-9. doi: 10.1245/s10434-0133437-0. Epub 2013 Dec 20. PMID: 24356798.
10. Kedrzycki MS, Leiloglou M, Ashrafian H, Jiwa N, Thiruchelvam PTR, Elson DS, Leff DR. Meta-analysis Comparing Fluorescence Imaging with Radioisotope and Blue Dye-Guided Sentinel Node Identification for Breast Cancer Surgery. Ann Surg Oncol. 2021 Jul;28(7):37383748. doi: 10.1245/s10434-020-09288-7. Epub 2020 Nov 6. PMID: 33156466; PMCID: PMC8184731.
11. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4. PMID: 33538338.
12. Thongvitokomarn S, Polchai N. Indocyanine Green Fluorescence Versus Blue Dye or Radioisotope Regarding Detection Rate of Sentinel Lymph Node Biopsy and Nodes Removed in Breast Cancer: A Systematic Review and Meta-Analysis. Asian Pac J Cancer Prev. 2020 May 1;21(5):1187-1195. doi: 10.31557/APJCP.2020.21.5.1187. PMID: 32458621; PMCID: PMC7541884.
13. Wang P, Shuai J, Leng Z, Ji Y. Meta-analysis of the application value of indocyanine green fluorescence imaging in guiding sentinel lymph node biopsy for breast cancer. Photodiagnosis Photodyn Ther. 2023 Sep; 43:103742. doi: 10.1016/j.pdpdt.2023.103742. Epub 2023 Aug 9. PMID: 37567333.
14. Wang C, Tong F, Cao Y, Liu P, Zhou B, Liu H, Cheng L, Liu M, Guo J, Xie F, Yang H, Wang S, Peng Y, Wang S. Long-term follow-up results of fluorescence and blue dye guided sentinel lymph node biopsy in early breast cancer. Breast Cancer Res Treat. 2021 Jul;188(2):361-368. doi: 10.1007/s10549-021-06196-6. Epub 2021 Mar 24. PMID: 3376
15. Xu Y, Yuan S, Chen M, Gong K, Liu Y, Li S, Xiong F, Pan Y, Cao J, Gong J, Luo N. Evaluation of indocyanine green combined with methylene blue staining in sentinel lymph node biopsy of breast cancer. Gland Surg. 2022 Sep;11(9):1489-1496. doi: 10.21037/gs-22-434. PMID: 36221275; PMCID: PMC9547706.
Review
For citations:
Nikiforov P.V., Afanasyeva L.N., Klimova T.M., Nikolaeva T.I., Ivanova F.G. Detection of malignant liver tumors and intrahepatic bile ducts in the Republic of Sakha (Yakutia). Yakut Medical Journal. 2025;(2):88-91. https://doi.org/10.25789/YMJ.2025.90.19
Views:
37
Email this article 